WCM INVESTMENT MANAGEMENT, LLC
Position in RYTM — Rhythm Pharmaceuticals, Inc.
CIK 1061186
LAGUNA BEACH, CA
Position in RYTM
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$8,943,688
+$1,932,167 QoQ
Shares Held
80,552
-0.1% QoQ
Ownership
0.117%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RYTM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WCM INVESTMENT MANAGEMENT, LLC holds $756,689,660 across 19 Biotechnology names. RYTM ranks #12 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,152,094 | $572,279,652 | |
| 2 | AXSM |
Axsome Therapeutics, Inc.
|
75,713 | $18,532,271 | |
| 3 | KYMR |
Kymera Therapeutics, Inc.
|
151,810 | $17,408,052 | |
| 4 | PCVX |
Vaxcyte, Inc.
|
243,502 | $14,154,771 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
|
44,570 | $14,088,131 | |
| 6 | TECH |
BIO-TECHNE Corp
|
197,933 | $13,983,966 | |
| 7 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
171,232 | $13,957,120 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
22,985 | $12,341,795 |
All Filings in RYTM
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,943,688 | 80,552 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $7,011,521 | 80,620 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $4,795,927 | 44,805 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $4,820,555 | 47,733 | Shares | Sole | 2025-11-04 | |
| No filing history on record for this holder in this stock. | ||||||